Highlights in the development of new therapies and novel drugs in treating melanoma
Why patient education is important in oncology
The toxicities associated with immunotherapy in lung cancer patients
The importance of biomarkers to optimize treatment with immunotherapy for melanoma
HOPA 2018/19: what’s next?